CD8A and neoplasm: In line with this, AhR activation promoted expression of immunosuppressive programmed death-ligand 1 (PDL1) in TAMs, and AhR inhibition mildly decreased the tumor size and improved the CD8 to Treg ratio in a separate glioblastoma model [54].